Risperdal, Risperidone News

Previous Presentation: These data debuted at the annual American Psychiatric Association congress in Washington, DC, May 3-8, 2008.

There are approximately 30,000 Albertans living with schizophrenia, including many right here in Central Alberta.

Context Cardiometabolic effects of second-generation antipsychotic medications are concerning but have not been sufficiently studied in pediatric and adolescent patients naive to antipsychotic medication.

Researchers at Zucker Hillside Hospital in Glen Oaks NY have found a link to substantial weight gain and hypercholesterolemia in children and adolescents taking many common psychiatric medications.

Featured Article Main Category: Psychology / Psychiatry Also Included In: Pediatrics / Children's Health ; Mental Health ; Obesity / Weight Loss / Fitness Article Date: 29 Oct 2009 - 11:00 PDT US researchers found that many children and teenagers treated with second generation antipsychotic drugs put on a significant amount of weight and also ...

Drugs called atypical antipsychotics caused kids to gain an average of 10 to 19 pounds in the first few months.

Many young children and adolescents taking drugs for severe psychiatric problems gain substantial weight and, in some cases, show increased levels of LDL cholesterol and triglycerides in their blood, researchers report in the Oct.

Many pediatric and adolescent patients who received second-generation antipsychotic medications experienced significant weight gain, along with varied adverse effects on cholesterol and triglyceride levels and other metabolic measures, according to a study in the October 28 issue of JAMA .

Up to a third of children and adolescents who took common antipsychotic drugs for the first time became overweight or obese in as little as 11 weeks, raising their risk for diabetes and heart disease, U.S. researchers said on Tuesday.

ARE we too quick to prescribe psychotropic medication for emotional and behavioural problems? Take Alzheimer's disease.

In biotech, a culture of creativity and team building helps top companies to work for weather a tough economy Linda Wang Lexicon Pharmaceuticals TEAMWORK Employees at Lexicon Pharmaceuticals participate in a variety of extracurricular activities, including this dragon-boat race in The Woodlands, Texas.

Five months after the surprise FDA approval of schizophrenia drug Fanapt , Vanda Pharmaceuticals Inc.

New Brunswick, NJ Johnson & Johnson today announced sales of $15.1 billion for the third quarter of 2009, a decrease of 5.3% as compared to the third quarter of 2008.

Dr Reddy's Laboratories has recalled some batches of four products from its key US market that were observed to contain some oversized tablets.

Why Olanzapine Beats Risperidone, Risperidone Beats Quetiapine, and Quetiapine Beats Olanzapine: An Exploratory Analysis of Head-to-Head Comparison Studies of Second-Generation Antipsychotics Export Am J Psychiatry , Vol.

Following our previous press release announcing that BL-1020 has successfully met its primary and secondary efficacy endpoints from the phase 2b EAGLE trial, we are pleased to report positive final results regarding the effects of BL-1020 on cognition.

Aurobindo Pharma has received the final approval for its Risperidone Oral Solution 1mg/mL from the US Food and Drug Administration .

Alkermes makes Risperdal Consta and other drugs. Shares of Alkermes Inc. declined after the Cambridge biotech said some Johnson & Johnson units have decided not to continue working on a joint venture to develop a four-week version of the antipsychotic drug Risperidone.

Alkermes said in an SEC filing J&J unit Ortho-McNeil Janssen Pharmaceuticals it will not pursue further development of an injectable formulation of risperidone.

Schering-Plough Corp.'s new drug for schizophrenia and bipolar disorder, Saphris, has been approved by the Food and Drug Administration, the company said Friday.